Company that guides clinicians towards personalised treatment and enhancing the quality of life for patients
Protyon has raised €600k across 1 funding round from 2 investors, most recently a Pre-Seed round in May 2023. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-12 | Pre-Seed | €600k |
| LUMO labs,NOM |
| View deal → |
